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Reply from the Authors
As we noticed, percutaneous interventions were
far more frequent than surgical revisions (96% vs.
4%). Specifically, in subjects screened only traditionally
(Group 2), 91% of interventions were percutaneous, 9%
surgical. As shown, subjects screened also by ultrasound
(Group 1) underwent more interventions per graft (2.1 ±
1.8 vs. 1.3 ± 1.0). Of them, 97.5% were percutaneous,
the remaining surgical. Basically, the groups differed in
the number of percutaneous interventions, while the rate
of surgical procedures was similar. Surgical interventions
were usually indicated in case of graft thrombosis, which
occurred later in Group 1.
Access infection necessitated graft extraction in four
subjects of group 1 and in three subjects of group 2—the
difference was not significant.
In group 1, 55% of angiographies were indicated by
the result of ultrasound. We discussed low sensitivity of
clinical diagnosis of access stenosis in our previous study
[1].
The main differences between our study and both
cited studies are in race and group size. Mentioned stud-
ies included approximately 33 subjects, mostly African
American, while we had over 90 participants per group,
all of them Caucasian.
In Ram’s study, the median graft age at inclusion was
94 and 196 days, respectively, while Lumsden and we
started to follow them at the time of access creation.
Another difference between our and both cited studies
was in the criterion of hemodynamically significant ac-
cess stenosis. We considered the stenosis significant only
when >50% reduction of lumen in B-mode was com-
bined with >doubling of peak blood velocity compared
to unaffected segment. This combination was strictly fol-
lowed and in uncertain results, the ultrasound was re-
peated 1 month after. Using this approach, we probably
indicated angiography later. We could only hypothesize
that untreated 50% stenosis is more stable than >60%
stenosis after successful angioplasty, as is experienced in
arterial interventions.
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Hepatitis C infection
and proteinuria
To the Editor: Derived from the NHANES III
database, it has been shown that hepatitis C infection
is independently associated with microalbuminuria [1];
however, no renal histologic data are available. We re-
port the case of a 45-old-year Caucasian nondiabetic
man with chronic hepatitis C who presented an isolated
(without hematuria or renal insufficiency) and constant
(based on repeated measurements of urinary albumin)
albuminuria (0.5 g per day), before interferon pegylated
and ribavirine treatment was started. His blood pres-
sure was normal (130/80 mm Hg) without treatment.
Any metabolic syndrome criteria [2] were not found.
Cryoglobulins remained undetectable as hepatitis C viral
load (by quantitative polymerase chain reaction tech-
nique). Transjugular kidney biopsy revealed a normal re-
nal parenchyma with only a slight mesangial IgA deposit
that could be explained by his liver status [3]. Moreover,
carotid Doppler study ruled out stenosis or thrombosis as
previously described by Ishizaka et al [4], who suggested
a relationship between hepatitis C infection and carotid
atherosclerosis.
The statistically significant age (older) and race
(African American) factors found to be strongly asso-
ciated with microalbuminuria in nondiabetic hepatitis C
[1] are not applicable in our adult Caucasian patient, who,
in addition, had controlled blood pressure. Pathophysi-
ology of isolated albuminuria in hepatitis C–infected pa-
tients remains unclear.
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